Cathie Wood's investing strategy centers around the concept of disruptive technology. Her family of Ark Invest exchange-traded funds (ETFs) specializes in companies at the razor's edge of pioneering fields like self-driving vehicles, personalized medicine, and futuristic medical devices.

This strategy has produced market-crushing returns in the past, but it is also an exceptionally risky way to invest and comes with a tremendous amount of volatility. For instance, Wood's flagship ARK Innovation ETF was up by over 740% at its peak back in early 2021, but it has since fallen by nearly 75% from its all-time high. 

This sharp pullback in many of Wood's top holdings might be a great time to bargain hunt. In particular, I'm still a bull on a handful of the fund manager's boldest picks in the areas of biotech and gene editing.

Continue reading

Source Fool.com